Koji Takeda

Author PubWeight™ 69.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med 2011 4.51
2 Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol 2008 3.27
3 Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 2006 2.85
4 Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 2006 2.60
5 Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. J Clin Oncol 2010 2.55
6 LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both. J Clin Oncol 2013 2.37
7 Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol 2009 2.30
8 Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer. Lung Cancer 2012 1.67
9 Efficacy of a hybrid assistive limb in post-stroke hemiplegic patients: a preliminary report. BMC Neurol 2011 1.62
10 Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study. J Clin Oncol 2010 1.51
11 Coronary artery bypass grafting in hemodialysis-dependent patients: analysis of Japan Adult Cardiovascular Surgery Database. Circ J 2012 1.49
12 Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center. ASAIO J 2015 1.48
13 Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study. J Thorac Oncol 2008 1.35
14 An invasive adenocarcinoma of the accessory parotid gland: a rare example developing from a low-grade cribriform cystadenocarcinoma? Diagn Pathol 2011 1.16
15 Prospective assessment of continuation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of pemetrexed. J Thorac Oncol 2013 1.16
16 Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 2010 1.14
17 Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials. Eur J Cancer 2010 1.06
18 A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer. J Thorac Oncol 2010 1.02
19 Highly enantioselective cyclopropenation reaction of 1-alkynes with α-alkyl-α-diazoesters catalyzed by dirhodium(II) carboxylates. Angew Chem Int Ed Engl 2011 0.94
20 A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patients. Jpn J Clin Oncol 2013 0.94
21 Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L. J Thorac Oncol 2013 0.91
22 Phase III study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer: JCOG 0509. J Clin Oncol 2014 0.89
23 Primary malignant pericardial mesothelioma presenting as pericardial constriction. Ann Thorac Cardiovasc Surg 2008 0.89
24 Incidence and Implications of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support. ASAIO J 2017 0.89
25 Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. Eur J Cardiothorac Surg 2011 0.89
26 Biotransformation of various alkanes using the Escherichia coli expressing an alkane hydroxylase system from Gordonia sp. TF6. Biosci Biotechnol Biochem 2004 0.88
27 Purification, characterization, and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica. Biochem Biophys Res Commun 2009 0.87
28 Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study. Oncotarget 2014 0.87
29 Percutaneous cardiopulmonary support after acute myocardial infarction at the left main trunk. Ann Thorac Cardiovasc Surg 2009 0.85
30 S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706). J Thorac Oncol 2011 0.85
31 Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices. ASAIO J 2016 0.84
32 Clinical relevance of sputum cytology and chest X-ray in patients with suspected lung tumors. Intern Med 2008 0.84
33 An assembled complex of palladium and non-cross-linked amphiphilic polymer: a highly active and recyclable catalyst for the Suzuki-Miyaura reaction. Org Lett 2002 0.84
34 Does stringent restrictive annuloplasty for functional mitral regurgitation cause functional mitral stenosis and pulmonary hypertension? Circulation 2011 0.83
35 Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group. Cancer Sci 2014 0.83
36 [Case of Toxocara canis larva migrans cured by additional treatment with albendazole]. Nihon Kokyuki Gakkai Zasshi 2008 0.83
37 The effect of voluntary training with family participation on early home discharge in patients with severe stroke at a convalescent rehabilitation ward. Eur Neurol 2012 0.83
38 Production of alpha, omega-alkanediols using Escherichia coli expressing a cytochrome P450 from Acinetobacter sp. OC4. Biosci Biotechnol Biochem 2006 0.83
39 Assessment of changes in mitral valve configuration with multidetector computed tomography: impact of papillary muscle imbrication and ring annuloplasty. Circulation 2010 0.82
40 Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer. Clin Lung Cancer 2012 0.82
41 Phase II study of gefitinib as a first-line therapy in elderly patients with pulmonary adenocarcinoma: West Japan Thoracic Oncology Group Study 0402. Jpn J Clin Oncol 2011 0.82
42 Heterogeneously integrated photonic-crystal lasers on silicon for on/off chip optical interconnects. Opt Express 2015 0.82
43 Phase I clinical study of the angiogenesis inhibitor TSU-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancer. J Thorac Oncol 2012 0.82
44 Phase I and pharmacologic study of weekly bolus topotecan for advanced non-small-cell lung cancer. Clin Lung Cancer 2010 0.81
45 The first clinical case in Japan of destination therapy using the Jarvik 2000 left ventricular assist device. J Artif Organs 2010 0.81
46 A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer. PLoS One 2013 0.81
47 Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses. Cancer Chemother Pharmacol 2006 0.81
48 Randomized phase 2 dose-finding study of weekly administration of darbepoetin alpha in anemic patients with lung or ovarian cancer receiving multicycle platinum-containing chemotherapy. Jpn J Clin Oncol 2010 0.80
49 [A case of intravascular lymphomatosis with no abnormal findings on chest computed tomography and with diffuse pulmonary uptake of 67Ga on scintigraphy]. Nihon Kokyuki Gakkai Zasshi 2006 0.80
50 Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301. J Thorac Oncol 2010 0.80
51 Severely calcified constrictive pericarditis simulating a mediastinal tumor and obstructing the right ventricular inflow tract. Ann Thorac Cardiovasc Surg 2007 0.80
52 Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401). J Thorac Oncol 2010 0.79
53 Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13. J Thorac Oncol 2014 0.79
54 Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol 2013 0.78
55 Highly active catalyst for the heterogeneous Suzuki-Miyaura reaction: assembled complex of palladium and non-cross-linked amphiphilic polymer. J Org Chem 2003 0.78
56 Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer. Eur J Cancer 2009 0.78
57 Serial multidetector computed tomography assessment of left ventricular reverse remodeling, mass, and regional wall stress after restrictive mitral annuloplasty in dilated cardiomyopathy. J Thorac Cardiovasc Surg 2011 0.78
58 Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004. Am J Clin Oncol 2012 0.78
59 Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer 2013 0.78
60 Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002). Int J Radiat Oncol Biol Phys 2007 0.78
61 Left ventricular mechanics following restrictive mitral annuloplasty for functional mitral regurgitation: two-dimensional speckle tracking echocardiographic study. Echocardiography 2012 0.78
62 [Safe and Effective Analgesia with Bilateral Continuous TAP Block for a Patient with Marfan Syndrome after Open Abdominal Aortic Aneurysm Repair]. Masui 2016 0.77
63 Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer. Anticancer Res 2011 0.77
64 Isolation and characterization of solvent-tolerant Pseudomonas putida strain T-57, and its application to biotransformation of toluene to cresol in a two-phase (organic-aqueous) system. J Ind Microbiol Biotechnol 2005 0.77
65 Impact of surgical ventricular reconstruction for ischemic dilated cardiomyopathy on restrictive filling pattern. Gen Thorac Cardiovasc Surg 2010 0.77
66 Successful bridge to recovery in a patient surviving fatal device-related complications after implantation of a Toyobo left ventricular assist system. J Artif Organs 2011 0.76
67 Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505. Clin Cancer Res 2008 0.76
68 Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2010 0.76
69 A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial. J Thorac Oncol 2009 0.76
70 Determination of micelle mass by electrospray ionization mass spectrometry. J Mass Spectrom 2005 0.76
71 Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure. Circulation 2012 0.75
72 A case of successful valve repair for aortic insufficiency associated with discrete subaortic stenosis. Ann Thorac Cardiovasc Surg 2011 0.75
73 Novel software package for quantifying local circumferential myocardial stress. Int J Cardiol 2010 0.75
74 Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation. ASAIO J 2017 0.75
75 Assessment of regional myocardial wall stress before and after surgical correction of functional ischaemic mitral regurgitation using multidetector computed tomography and novel software system. Eur J Cardiothorac Surg 2010 0.75
76 Wavelength-multiplexed optical packet switching using InP phased-array switch. Opt Express 2009 0.75
77 Systematic study of thresholdless oscillation in high-β buried multiple-quantum-well photonic crystal nanocavity lasers. Opt Express 2016 0.75
78 [Side effects of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)]. Nihon Rinsho 2015 0.75
79 Directly modulated buried heterostructure DFB laser on SiO₂/Si substrate fabricated by regrowth of InP using bonded active layer. Opt Express 2014 0.75
80 [The importance of bone management for cancer bone disease--positioning of zoledronic acid for multiple myeloma, genitor-urinary cancers (renal cancer and prostate cancer), lung cancer and breast cancer]. Gan To Kagaku Ryoho 2012 0.75
81 Enantioselective cycloaddition of carbonyl ylides with arylallenes using Rh2(S-TCPTTL)4. Org Biomol Chem 2013 0.75
82 40-Gb/s directly-modulated photonic crystal lasers under optical injection-locking. Opt Express 2011 0.75
83 Aortic valvar involvement in patients undergoing closure of ventricular septal defect via the pulmonary trunk. Int J Cardiol 2007 0.75
84 Use of Durable Continuous-Flow Ventricular Assist Devices in Patients on Immunosuppression. ASAIO J 2017 0.75
85 Systematic hole-shifting of L-type nanocavity with an ultrahigh Q factor. Opt Lett 2014 0.75
86 A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904). Jpn J Clin Oncol 2010 0.75
87 [A case of a septic pulmonary embolism-related implanted central venous port]. Gan To Kagaku Ryoho 2013 0.75
88 Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer. Lung Cancer 2010 0.75
89 Chronic expanding intrapericardial hematoma after coronary artery bypass surgery presenting with congestive heart failure. Ann Thorac Cardiovasc Surg 2008 0.75
90 [The factors determining diagnostic accuracy in CT-guided percutaneous needle biopsy of small pulmonary nodules]. Nihon Kokyuki Gakkai Zasshi 2002 0.75
91 [Persistent apnea in an obese patient with myotonic dystrophy]. Masui 2005 0.75
92 Restrictive mitral annuloplasty with or without surgical ventricular restoration in ischemic dilated cardiomyopathy with severe mitral regurgitation. Circulation 2011 0.75
93 The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg/m²) in Japanese patients with advanced or recurrent solid tumors. Jpn J Clin Oncol 2011 0.75
94 All-optical switching for 10-Gb/s packet data by using an ultralow-power optical bistability of photonic-crystal nanocavities. Opt Express 2015 0.75
95 Room-temperature continuous-wave operation of lateral current injection wavelength-scale embedded active-region photonic-crystal laser. Opt Express 2012 0.75
96 Catalytic asymmetric synthesis of the endo-6-aryl-8-oxabicyclo[3.2.1]oct-3-en-2-one natural product from Ligusticum chuanxing via 1,3-dipolar cycloaddition of a formyl-derived carbonyl ylide using Rh2(S-TCPTTL)4. J Org Chem 2010 0.75
97 InGaAs nano-photodetectors based on photonic crystal waveguide including ultracompact buried heterostructure. Opt Express 2013 0.75
98 Short-term continuous-flow ventricular assist devices. Curr Opin Cardiol 2014 0.75
99 [Evaluation of recurrence rates on change in hormone receptor and human epidermal growth factor receptor 2 status after neo-adjuvant chemotherapy in breast cancer patients]. Gan To Kagaku Ryoho 2014 0.75
100 [Subset analysis of data in the Japanese patients with NSCLC from IDEAL 1 study on gefitinib]. Gan To Kagaku Ryoho 2004 0.75
101 Membrane distributed-reflector laser integrated with SiOx-based spot-size converter on Si substrate. Opt Express 2016 0.75
102 Combined Therapy of Ventricular Assist Device and Extracorporeal Membrane Oxygenation for Profound Acute Cardiopulmonary Failure. ASAIO J 2017 0.75